Eli Lilly has a new partnership with the US National Center for Advancing Translational Sciences, reports the Nature News Blog. Lilly is going to screen more than 3,800 approved and investigational drugs that are part of the center's collection, and the company says it will post its results publicly.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.